JAK/STAT3-regulated fatty acid β-oxidation is critical for breast cancer stem cell self-renewal and chemoresistance T Wang, JF Fahrmann, H Lee, YJ Li, SC Tripathi, C Yue, C Zhang, ... Cell metabolism 27 (1), 136-150. e5, 2018 | 770 | 2018 |
Mitochondrial pyruvate import promotes long-term survival of antibody-secreting plasma cells WY Lam, AM Becker, KM Kennerly, R Wong, JD Curtis, EM Llufrio, ... Immunity 45 (1), 60-73, 2016 | 272 | 2016 |
Rise of deep learning for genomic, proteomic, and metabolomic data integration in precision medicine D Grapov, J Fahrmann, K Wanichthanarak, S Khoomrung Omics: a journal of integrative biology 22 (10), 630-636, 2018 | 232 | 2018 |
Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance A Mukherjee, CY Chiang, HA Daifotis, KM Nieman, JF Fahrmann, ... Cancer research 80 (8), 1748-1761, 2020 | 208 | 2020 |
Mass spectral feature list optimizer (MS-FLO): a tool to minimize false positive peak reports in untargeted liquid chromatography–mass spectroscopy (LC-MS) data processing BC DeFelice, SS Mehta, S Samra, T Cajka, B Wancewicz, JF Fahrmann, ... Analytical chemistry 89 (6), 3250-3255, 2017 | 181 | 2017 |
Genomic, proteomic, and metabolomic data integration strategies K Wanichthanarak, JF Fahrmann, D Grapov Biomarker insights 10, BMI. S29511, 2015 | 181 | 2015 |
Lead-time trajectory of CA19-9 as an anchor marker for pancreatic cancer early detection JF Fahrmann, CM Schmidt, X Mao, E Irajizad, M Loftus, J Zhang, N Patel, ... Gastroenterology 160 (4), 1373-1383. e6, 2021 | 149 | 2021 |
Metabolomics and transcriptomics identify pathway differences between visceral and subcutaneous adipose tissue in colorectal cancer patients: the ColoCare study DB Liesenfeld, D Grapov, JF Fahrmann, M Salou, D Scherer, R Toth, ... The American journal of clinical nutrition 102 (2), 433-443, 2015 | 146 | 2015 |
Deep metabolome: Applications of deep learning in metabolomics Y Pomyen, K Wanichthanarak, P Poungsombat, J Fahrmann, D Grapov, ... Computational and Structural Biotechnology Journal 18, 2818-2825, 2020 | 139 | 2020 |
A plasma-derived protein-metabolite multiplexed panel for early-stage pancreatic cancer JF Fahrmann, LE Bantis, M Capello, G Scelo, JB Dennison, N Patel, ... JNCI: Journal of the National Cancer Institute 111 (4), 372-379, 2019 | 116 | 2019 |
MCAM mediates chemoresistance in small-cell lung cancer via the PI3K/AKT/SOX2 signaling pathway SC Tripathi, JF Fahrmann, M Celiktas, M Aguilar, KD Marini, MK Jolly, ... Cancer Research 77 (16), 4414-4425, 2017 | 113 | 2017 |
Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma WR Wikoff, D Grapov, JF Fahrmann, B DeFelice, WN Rom, HI Pass, K Kim, ... Cancer prevention research 8 (5), 410-418, 2015 | 101 | 2015 |
Role of CPS1 in cell growth, metabolism, and prognosis in LKB1-inactivated lung adenocarcinoma M Çeliktaş, I Tanaka, S Chandra Tripathi, JF Fahrmann, ... Journal of the National Cancer Institute 109 (3), djw231, 2017 | 89 | 2017 |
An in silico MS/MS library for automatic annotation of novel FAHFA lipids Y Ma, T Kind, A Vaniya, I Gennity, JF Fahrmann, O Fiehn Journal of cheminformatics 7, 1-5, 2015 | 89 | 2015 |
Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids YJ Li, JF Fahrmann, M Aftabizadeh, Q Zhao, SC Tripathi, C Zhang, ... Cell reports 39 (9), 2022 | 87 | 2022 |
Omega-6 and omega-3 oxylipins are implicated in soybean oil-induced obesity in mice P Deol, J Fahrmann, J Yang, JR Evans, A Rizo, D Grapov, M Salemi, ... Scientific reports 7 (1), 12488, 2017 | 86 | 2017 |
Plasma-derived extracellular vesicle proteins as a source of biomarkers for lung adenocarcinoma J Vykoukal, N Sun, C Aguilar-Bonavides, H Katayama, I Tanaka, ... Oncotarget 8 (56), 95466, 2017 | 77 | 2017 |
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer J Vykoukal, JF Fahrmann, JR Gregg, Z Tang, S Basourakos, E Irajizad, ... Nature communications 11 (1), 4279, 2020 | 73 | 2020 |
Integrated metabolomics and proteomics highlight altered nicotinamide and polyamine pathways in lung adenocarcinoma JF Fahrmann, D Grapov, K Wanichthanarak, BC DeFelice, MR Salemi, ... Carcinogenesis 38 (3), 271-280, 2017 | 72 | 2017 |
Blood-based biomarker panel for personalized lung cancer risk assessment JF Fahrmann, T Marsh, E Irajizad, N Patel, E Murage, J Vykoukal, ... Journal of Clinical Oncology 40 (8), 876-883, 2022 | 71 | 2022 |